consequently , in 1985 ifo was incorporated into first-line chemotherapy for newly diagnosed patients ( replacing cyclophosphamide ) and given in combination with vincristine , actinomycin d , and adriamycin ( vaia ) in patients considered to be at high risk for relapse .
C0020823
ifo
C0010583
cyclophosphamide